400 Howard Street,
San Francisco , CA, 94105
San Francisco , CA, 94105
Summary
The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in companies outside the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
As part of its strategy, the fund employs a passive or indexing approac More
Webiste
Directors
Nov 13, 2023- John E. Kerrigan
- Richard L. Fagnani
- Robert S. Kapito
- Drew E. Lawton
- John E. Martinez
- Salim Ramji
- Madhav V. Rajan
- Jane D. Carlin
- Cecilia H. Herbert
Chief Compliance Officer
- Aaron Wasserman
Price
- $ 77.08 ( -1.6 )
-
Apr 10, 2025Last Close
- Net Assets
-
$7.8B
Apr 24, 2024
- 52-Week High/Low
- $84.9 - $73.1
- Expense Ratio
- -
Performance
YTD
0%
3 Year
5.52%
5 Year
39.66%
Best
99.93%
2016
Worst
-98.73%
2012
Company Name |
Holding |
Novo Nordisk A/S | 2.64 % |
ASML Holding NV | 2.24 % |
SAP SE | 1.59 % |
AstraZeneca PLC | 1.5 % |
Novartis AG | 1.36 % |
Nestle SA | 1.27 % |
Shell PLC | 1.26 % |
Schneider Electric SE | 1.16 % |
LVMH Moet Hennessy Louis Vuitton SE | 1.14 % |
Toyota Motor Corp | 1.09 % |
More | 1.09 % |
NAV
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ESGD | 0% | 7.8% | 14.9% | -15.6% | 9.4% | 3.9% | 19.4% | -13.3% | 25.1% | 99.9% | |
S&P 500 | -8.8% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
q1 | 0% | 5.8% | 9.3% | -5.3% | 3.8% | -22.4% | 10.1% | -0.8% | 7.8% | 0% | ||||
q2 | 0% | -2.8% | 1.5% | -14.9% | 7% | 14% | 0.6% | -0.6% | 6% | 0% | ||||
q3 | 0% | 0% | -5.2% | -10.6% | -0.8% | 2.6% | -0.9% | 2.7% | 5.8% | 0.5% | ||||
q4 | 0% | 0% | 10.9% | 17.1% | 1.4% | 14.6% | 6.9% | -12.7% | 3.6% | -1.9% |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
2024 | -0.4% | 2.7% | 3.4% | -3.2% | 4.2% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |